These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 448089)

  • 1. Activation of human complement by liposomes: a model for membrane activation of the alternative pathway.
    Cunningham CM; Kingzette M; Richards RL; Alving CR; Lint TF; Gewurz H
    J Immunol; 1979 Apr; 122(4):1237-42. PubMed ID: 448089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of membrane phospholipids on activation of the alternative complement pathway.
    Mold C
    J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activation of complement by isolated human heart subcellular membranes.
    Giclas PC; Pinckard RN; Olson MS
    J Immunol; 1979 Jan; 122(1):146-51. PubMed ID: 762412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
    Wahn V; Müller W; Rieger C; Rother U
    Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.
    Gronski P; Bodenbender L; Kanzy EJ; Piepenbrock M; Seiler FR
    Immunobiology; 1986 Apr; 171(3):252-62. PubMed ID: 3011651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative complement pathway activation by C4b deposited during classical pathway activation.
    Matsushita M; Okada H
    J Immunol; 1986 Apr; 136(8):2994-8. PubMed ID: 2937839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the alternative pathway of complement by human peripheral nerve myelin.
    Koski CL; Vanguri P; Shin ML
    J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the classical pathway of complement by Hageman factor fragment.
    Ghebrehiwet B; Silverberg M; Kaplan AP
    J Exp Med; 1981 Mar; 153(3):665-76. PubMed ID: 7252410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that C1s participates in the alternative complement pathway.
    Volanakis JE; Schultz DR; Stroud RM
    Int Arch Allergy Appl Immunol; 1976; 50(1):68-80. PubMed ID: 1244208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol-dependent human complement activation resulting in damage to liposomal model membranes.
    Alving CR; Richards RL; Guirguis AA
    J Immunol; 1977 Jan; 118(1):342-7. PubMed ID: 830757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM; Bryan CS; Hawiger J; Colley DG
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.
    Vanguri P; Koski CL; Silverman B; Shin ML
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3290-4. PubMed ID: 6954480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of C-reactive protein and complement with liposomes.
    Richards RL; Gewurz H; Osmand AP; Alving CR
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5672-6. PubMed ID: 271994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction.
    Pinckard RN; Olson MS; Giclas PC; Terry R; Boyer JT; O'Rourke RA
    J Clin Invest; 1975 Sep; 56(3):740-50. PubMed ID: 808560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation by pneumococci associated with acute otitis media.
    Prellner K
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
    Mold C; Walter EI; Medof ME
    J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
    Loos M; Bitter-Suermann D
    Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.